The National Blood Agreement describes the process for determining the products which are supplied under the National Blood Arrangements. Products which are agreed by Health Ministers under the National Blood Agreement are funded 63% by the Commonwealth and 37% by the states and territories.
Changes to the products supplied under the National Blood Agreement are subject to an approval process. See Changes to National Product Price List for more information.
There may be blood and blood products approved by the Therapeutic Goods Administration (TGA)(link is external)(link is external) for supply in Australia that are not included on the National Product Price List. It may be possible for these products to be purchased directly from the supplier. However, payments for these purchases must be arranged separately, and are not funded under the National Blood Agreement.
The National Blood Authority is responsible for the procurement of products agreed by Health Ministers. The products are then included on the National Product Price List and forwarded to Health Ministers for approval as part of the National Supply Plan and Budget.
National Product Price List
TABLE: Plasma and Recombinant Products at 1 July 2023
|
Product Type |
Name |
Presentation |
Supplier |
Price |
|---|---|---|---|---|
|
Albumin |
Albumex |
20% 10ml |
CSL Behring |
$18.25 |
|
20% 100ml |
$71.97 |
|||
|
4% 50ml |
$18.25 |
|||
|
4% 500ml |
$71.97 |
|||
|
Albumin |
ALBUREX 20 AU |
10g/50mL |
$91.26* |
|
|
20g/100mL |
$71.97 |
|||
|
Factor VIIa (recombinant - imported) |
NovoSeven |
1mg |
Novo-Nordisk |
$1,250.00 |
|
2mg |
$2,500.00 |
|||
|
5mg |
$6,250.00 |
|||
|
8mg |
$10,000.00 |
|||
|
Factor VIII Activated Prothrombin Complex Concentrate |
FEIBA |
500 U |
Takeda |
$1,140.00 |
|
2500 U |
$5,700.00 |
|||
|
Factor VIII (recombinant - imported) |
ADVATE |
250 IU |
Takeda |
# |
|
500 IU |
# |
|||
|
1000 IU |
# |
|||
|
1500 IU |
# |
|||
|
2000 IU |
# |
|||
|
3000 IU |
# |
|||
|
Factor VIII (recombinant - imported) |
ADYNOVATE |
250 IU |
Takeda |
# |
|
500 IU |
# |
|||
|
1000 IU |
# |
|||
|
1500 IU |
# |
|||
|
2000 IU |
# |
|||
|
3000 IU |
# |
|||
|
Factor VIII (recombinant - imported) |
ELOCTATE |
250 IU |
Sanofi-Aventis |
# |
|
500 IU |
# |
|||
|
1000 IU |
# |
|||
|
2000 IU |
# |
|||
|
3000 IU |
# |
|||
|
Factor VIII (plasma derived - domestic) |
Biostate
|
250 IU |
CSL Behring |
$256.76 [1] |
|
500 IU |
$513.54 [1] |
|||
|
1000 IU |
$1,027.07 [1] |
|||
|
Factor VIII (recombinant - imported)
|
Xyntha |
250 IU |
Pfizer Australia |
# |
|
500 IU |
# |
|||
|
1000 IU |
# |
|||
|
2000 IU |
# |
|||
|
3000 IU |
# |
|||
|
Factor IX (plasma derived - domestic) |
MonoFIX |
1000 IU |
CSL Behring |
$1,027.07 [1] |
|
Factor IX (recombinant - imported) |
BeneFIX |
250 IU |
Pfizer Australia |
# |
|
500 IU |
# |
|||
|
1000 IU |
# |
|||
|
2000 IU |
# |
|||
|
3000 IU |
# |
|||
|
Factor IX (recombinant - imported) |
ALPROLIX |
250 IU |
Sanofi-Aventis |
# |
|
500 IU |
# |
|||
|
1000 IU |
# |
|||
|
2000 IU |
# |
|||
|
3000 IU |
# |
|||
|
Factor XI (plasma derived - imported) |
Factor XI |
1 IU |
CSL Behring |
$15.62 |
|
Factor XIII (plasma derived - imported) |
Fibrogammin |
250 IU |
CSL Behring |
$220.69 |
|
1250 IU |
$1,103.46 |
|||
|
Factor XIII (recombinant - imported) |
NovoThirteen |
2500 IU |
Novo Nordisk |
$30,000.00 |
|
Emicizumab (bi-functional monoclonal antibody) |
Hemlibra |
30mg/1ml |
Roche |
# |
|
60mg/0.4ml |
# |
|||
|
105mg/0.7ml |
# |
|||
|
150mg/1ml |
# |
|||
|
Human prothrombin complex (plasma derived - domestic) |
Prothrombinex |
500 IU |
CSL Behring |
$327.40 [1] |
|
Fibrinogen concentrate (plasma derived - imported) |
RiaSTAP |
1g |
CSL Behring |
$889.01 |
|
Human C1 esterase inhibitor concentrate |
Berinert IV |
500 IU |
CSL Behring |
# |
|
Berinert IV |
1500 IU |
# |
||
|
Berinert SC |
2000 IU |
# |
||
|
Berinert SC |
3000 IU |
# |
||
|
Protein C concentrate (plasma derived - imported) |
Ceprotin |
500 IU |
Takeda |
$1,245.00 |
|
1000 IU |
$2,490.00 |
|||
|
Antithrombin III concentrate (plasma derived - domestic) |
Thrombotrol |
1000 IU |
CSL Behring |
$1,656.15 [1] |
|
Intravenous immunoglobulin (IVIg) |
Intragam 10 |
2.5g/25ml |
CSL Behring |
$147.68 [1] |
|
10g/100ml |
$590.72 [1] |
|||
|
20g/200ml |
$1,181.44 [1] |
|||
|
Intravenous immunoglobulin (IVIg) (plasma derived – domestic) |
PRIVIGEN AU |
5g/50mL |
CSL Behring |
$295.36 [1] |
|
10g/100mL |
$590.72 [1] |
|||
|
20g/200mL |
$1,181.44 [1] |
|||
|
IVIg (plasma derived -imported) |
|
5g/50ml |
CSL Behring |
# |
|
10g/100ml |
# |
|||
|
20g/200ml |
# |
|||
|
40g/400ml |
# |
|||
|
IVIg (plasma derived - imported) |
Flebogamma 5% DIF |
2.5g/50ml |
|
# |
|
Flebogamma 5% DIF |
5g/100ml |
# |
||
|
Flebogamma 5% DIF |
10g/200ml |
# |
||
|
Flebogamma 5% DIF |
20g/400ml |
# |
||
|
Flebogamma 10% DIF |
5g/50ml |
# |
||
|
Flebogamma 10% DIF |
10g/100ml |
# |
||
|
Flebogamma 10% DIF |
20g/200ml |
# |
||
|
IVIg (plasma derived - imported) |
Gamunex 10% |
5g/50ml |
Grifols Australia |
# |
|
Gamunex 10% |
10g/100ml |
# |
||
|
Gamunex 10% |
20g/200ml |
# |
||
|
IVIg (plasma derived –imported) |
Octagam 10% |
5g/50ml |
Octapharma Australia |
# |
|
Octagam 10% |
10g/100ml |
# |
||
|
Octagam 10% |
20g/200ml |
# |
||
|
IVIg (plasma derived –imported) |
Kiovig 10% |
5g/50ml |
Takeda Pharmaceutical Australia |
# |
|
Kiovig 10% |
10g/100ml |
# |
||
|
Kiovig 10% |
20g/200ml |
# |
||
|
Kiovig 10% |
30g/200ml |
# |
||
|
SCIg (plasma derived – domestic) |
Evogam |
16% 0.8g/5ml |
CSL Behring |
$47.26 [1] |
|
16% 3.2g/20ml |
$189.03 [1] |
|||
|
SCIg (plasma derived –domestic) |
HIZENTRA AU |
20% 5mL |
CSL Behring |
$59.07 [1] |
|
20% 20mL |
$236.29 [1] |
|||
|
SCIg (plasma derived - imported) |
Hizentra |
1g/5ml |
|
# |
|
2g/10ml |
# |
|||
|
4g/20ml |
# |
|||
|
10g/50ml |
# |
|||
|
SCIg (plasma derived -imported) |
CUVITRU 20% |
1g/5ml |
Takeda Pharmaceuticals Australia |
# |
|
2g/10ml |
# |
|||
|
4g/20ml |
# |
|||
|
8g/40ml |
# |
|||
| SCIg (plasma derived - imported) | Xembify 20% | 1g/5ml | Grifols Australia | # |
| 2g/10ml | # | |||
| 4g/20ml | # | |||
| 10g/50ml | # | |||
|
Normal immunoglobulin (NIg) (plasma derived - domestic) |
Normal Immunoglobulin |
2ml (0.32g) |
CSL Behring |
$37.26 [1] |
|
5ml (0.80g) |
$61.08 [1] |
|||
|
CMV immunogobulin (plasma derived - domestic) |
CMV Immunoglobulin |
1.5 million units |
CSL Behring |
$1,416.15 [1] |
|
Hepatitis B immunoglobulin (plasma derived - domestic) |
Hepatitis B Immunoglobulin
|
100 IU (2ml) |
CSL Behring |
$51.77 [1] |
|
400 IU (5ml) |
$118.51 [1] |
|||
|
RhD immunoglobulin (plasma derived - imported) |
Rhophylac |
1500 IU |
CSL Behring |
$465.21 |
|
RhD immunoglobulin (Glycine Formulation) (plasma derived - domestic) |
RhD Immunoglobulin |
250 IU |
CSL Behring |
$35.06 [1] |
|
625 IU |
$87.62 [1] |
|||
|
Tetanus immunoglobulin (plasma derived - domestic) |
Tetanus Immunoglobulin |
250 IU |
CSL Behring |
$51.18 [1] |
|
4000 IU |
$818.61 [1] |
|||
|
Zoster immunoglobulin (plasma derived - domestic) |
Zoster Immunoglobulin |
200 IU |
CSL Behring |
$324.57 [1] |
* - the price for the 10g/50mL presentation of ALBUREX 20 AU is higher than the 20g/100mL
# - price not disclosed
TABLE: Fresh product prices at 1 July 2023
|
Product Type |
Name |
Presentation |
Supplier |
Price |
|---|---|---|---|---|
|
Red blood cells
|
Whole blood (WB) red cells leucodepleted |
>200ml [2] |
Australian Red Cross Lifeblood |
$375.03 |
|
Red blood cells |
WB paediatric red cells leucodepleted (Set of 4) |
25-100ml [2] |
Australian Red Cross Lifeblood |
$446.42 |
|
Red blood cells |
WB washed red cells leucodepleted |
>130ml [2] |
Australian Red Cross Lifeblood |
$436.06 |
|
Platelets |
WB platelet pool leucodepleted |
>160ml [2] |
Australian Red Cross Lifeblood |
$257.02
|
|
Platelets |
Apheresis platelet leucodepleted |
100-400ml [2] |
Australian Red Cross Lifeblood |
$549.70 |
|
Platelets |
Paediatric apheresis platelet leucodepleted (set of 3) |
40-60ml [2] |
Australian Red Cross Lifeblood |
$700.71 |
|
Clinical fresh frozen plasma (FFP) |
WB clinical FFP |
295ml+/-10% [2] |
Australian Red Cross Lifeblood |
$155.75
|
|
Clinical fresh frozen plasma (FFP) |
WB paediatric clinical FFP (set of 4) |
74ml+/-10% [2]
|
Australian Red Cross Lifeblood |
$181.98
|
|
Clinical fresh frozen plasma (FFP) |
Apheresis clinical FFP |
295ml +/-10% [2] |
Australian Red Cross Lifeblood |
$220.30 |
|
Cryoprecipitate |
WB cryoprecipitate |
30-40ml [2] |
Australian Red Cross Lifeblood |
$166.63 |
|
Cryoprecipitate |
Apheresis cryoprecipitate |
60ml+/-10%[2] |
Australian Red Cross Lifeblood |
$340.90 |
|
Cryo-depleted plasma |
WB cryo-depleted plasma |
165ml [2] |
Australian Red Cross Lifeblood |
$154.99 |
|
Cryo-depleted plasma |
Apheresis cryo-depleted plasma |
500ml [2] |
Australian Red Cross Lifeblood |
$318.45 |
|
Other products |
Autologous donation |
NA |
Australian Red Cross Lifeblood |
$384.57 |
|
Other products |
Therapeutic Venesections for |
N/A – collection |
Australian Red Cross Lifeblood |
$533.61 |
|
Other products |
Serum eye drops |
Single Collection |
Australian Red Cross Lifeblood |
$224.83 |
|
Plasma for Fractionation |
Plasma for Fractionation [3] |
Presentation size NA, |
Australian Red Cross Lifeblood |
$371.31 |
- The price does not include the starting plasma provided to CSL Behring by the Australian Red Cross Lifeblood.
- The presentation volume for a typical unit content is specified in the Australian Red Cross Lifeblood's Blood Component Information, 2023.
- Plasma for Fractionation is supplied to CSL Behring for manufacturing plasma derived products.
Print
Email this page